IP Library Granted Patent US 8,034,341
Granted Patent B2
US 8,034,341 · App. 12/546,230 · Granted Oct 11, 2011

Methods of inhibiting tumor growth using blocking antibodies to IL-23R

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,341
App. No.
12/546,230
Granted
Oct 11, 2011
Kind
B2
Abstract

Provided are methods of treatment for tumors. In particular, methods are provided for modulating activity of a cytokine molecule and its receptor.

Claims (21)

1. A method of treating a subject suffering from a cancer or tumor comprising administering to the subject an effective amount of a binding composition comprising an antigen-binding site of a blocking antibody that specifically binds to a polypeptide comprising residues 1-606 of SEQ ID NO: 6.

2. The method of claim 1 , wherein the binding composition inhibits:

a) growth of the cancer or tumor;

b) cachexia;

c) anorexia; or

d) angiogenesis.

3. The method of claim 1 , wherein the cancer or tumor is of the:

a) gastrointestinal tract;

b) respiratory tract;

c) reproductive system; or

d) endocrine system.

4. The method of claim 1 , wherein the cancer or tumor is:

a) colon cancer;

b) ovarian cancer;

c) a melanoma; or

d) breast cancer.

5. The method of claim 1 , wherein the binding composition comprises a polyclonal antibody.

6. The method of claim 1 , wherein the binding composition comprises a monoclonal antibody.

7. The method of claim 1 , wherein the binding composition comprises a humanized antibody, or a fragment thereof.

8. The method of claim 1 , wherein the binding composition comprises an Fab, Fv, or F(ab′) 2 fragment.

9. A method of treating a subject suffering from a cancer or tumor comprising administering to the subject an effective amount of a binding composition comprising an antigen-binding site of a blocking antibody that specifically binds to a polypeptide comprising the sequence of SEQ ID NO: 6.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →